Research Paper Volume 15, Issue 24 pp 15535—15556
Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma
Figure 10. Correlation between gene expression and clinicopathological staging characteristics. (A) Expression of SLC6A3 in different pathologic stages. (B, C) Expression of MITD1 in different pathologic stages and pathology M stage. (D) Expression of CCS, (E) LIPT2, and (F) PDHB in different radiation therapy. (G) Expression of PDHA1 in different pathologic stages, (H) pathology M stage, (I) pathology N stage, (J) pathology T stage, (K) radiation therapy, and (L) number of lymph nodes. *P < 0.05, **P < 0.01.